Evidence map›Paper›PMID 35536256›Full record

ArticleNucleic acids research2022

Control of bacterial immune signaling by a WYL domain transcription factor.

Chelsea L Blankenchip, Justin V Nguyen, Rebecca K Lau, Qiaozhen Ye, Yajie Gu, Kevin D Corbett

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
8.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Modified DNA substrate selectivity by GmrSD-family Type IV restriction enzyme BrxU.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2025
    Article
  12. Defence systems encoded by core genomic islands of seventh pandemicPhilosophical transactions of the Royal Society of London. Series B, Biological sciences · 2025
    Review
  13. Article
  14. Article
  15. The defensome of prokaryotes in aquifers.Nature communications · 2025
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Chelsea L BlankenchipBiomedical Sciences Graduate Program, University of California, San Diego, La Jolla, CA, USA.
Justin V NguyenDepartment of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, CA, USA.
Rebecca K LauBiomedical Sciences Graduate Program, University of California, San Diego, La Jolla, CA, USA.
Qiaozhen YeDepartment of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, CA, USA.
Yajie GuDepartment of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, CA, USA.
Kevin D CorbettDepartment of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, CA, USA.ORCID 0000-0001-5854-2388
University of California San Diego · US

Funding

Molecular Biophysics Training Grant at UC San DiegoT32GM139795 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Galia Debelouchina, ELIZABETH A. KOMIVES · 2021 to 2026
$3.0M
Molecular mechanisms of nucleic acid recognition and maintenance in meiosis and innate immunityR35GM144121 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Kevin Daniel Corbett · 2022 to 2026
$2.7M
Training Program in Quantitative Integrative BiologyT32GM127235 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI HWA, TERENCE · 2018 to 2022
$1.3M
Molecular mechanisms of the first-identified bacterial HORMA and Pch2-like proteins in a novel second-messenger signaling pathwayR21AI148814 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI CORBETT, KEVIN DANIEL · 2020 to 2021
$409k
Defining the role of cyclic trinucleotide signaling in bacteriophage immunity through the activation and regulation of HORMA-associated cGAS/DncV-related nucleotidyltransferasesF31GM137600 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI LAU, REBECCA KAVALER · 2020 to 2022
$95k
NIAID NIH HHS R21 AI148814NIGMS NIH HHS F31 GM137600NIGMS NIH HHS R35 GM144121NIGMS NIH HHS T32 GM127235NIGMS NIH HHS T32 GM139795
6 · The paper itself

Abstract

Bacteria use diverse immune systems to defend themselves from ubiquitous viruses termed bacteriophages (phages). Many anti-phage systems function by abortive infection to kill a phage-infected cell, raising the question of how they are regulated to avoid cell killing outside the context of infection. Here, we identify a transcription factor associated with the widespread CBASS bacterial immune system, that we term CapW. CapW forms a homodimer and binds a palindromic DNA sequence in the CBASS promoter region. Two crystal structures of CapW suggest that the protein switches from an unliganded, DNA binding-competent state to a ligand-bound state unable to bind DNA. We show that CapW strongly represses CBASS gene expression in uninfected cells, and that phage infection causes increased CBASS expression in a CapW-dependent manner. Unexpectedly, this CapW-dependent increase in CBASS expression is not required for robust anti-phage activity, suggesting that CapW may mediate CBASS activation and cell death in response to a signal other than phage infection. Our results parallel concurrent reports on the structure and activity of BrxR, a transcription factor associated with the BREX anti-phage system, suggesting that CapW and BrxR are members of a family of universal defense signaling proteins.

Indexed as

BacteriaTranscription FactorsBacteriophagesLigandsSignal TransductionLigandsTranscription Factors

Identifiers

PMID35536256
PMCPMC9122588
OpenAlexW4226356607

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.